Lopaschuk GD, Verma S (2020) Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: a state-of-the-art review
C., Davinelli, S., & Scapagnini, G
As weight decreases, the body often fights back by increasing appetite hormones and lowering energy use
GLP-1 is a peptide secreted by L-type enteroendocrine cells in the ileum and colon in response to different nutrients, mainly glucose and lipids, whereas glucose-dependent insulinotropic polypeptide is produced by K cells present in the duodenum and the first portion of the jejunum
Storage challenges do not disqualify treatment, but proactive planningsuch as office storage or alternative delivery timingensures consistent access and proper handling